Skip to main content
Advertisement
  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center

Advanced Search

Main menu

  • Neurology.org
  • Journals
    • Neurology
    • Clinical Practice
    • Education
    • Genetics
    • Neuroimmunology & Neuroinflammation
  • Online Sections
    • Neurology Video Journal Club
    • Inclusion, Diversity, Equity, Anti-racism, & Social Justice (IDEAS)
    • Innovations in Care Delivery
    • Practice Buzz
    • Practice Current
    • Residents & Fellows
    • Without Borders
  • Collections
    • COVID-19
    • Disputes & Debates
    • Health Disparities
    • Infographics
    • Neurology Future Forecasting Series
    • Null Hypothesis
    • Patient Pages
    • Topics A-Z
    • Translations
  • Podcast
  • CME
  • About
    • About the Journals
    • Contact Us
    • Editorial Board
  • Authors
    • Submit a Manuscript
    • Author Center
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

User menu

  • Subscribe
  • My Alerts
  • Log in
  • Log out

Search

  • Advanced search
Neurology
Home
The most widely read and highly cited peer-reviewed neurology journal
  • Subscribe
  • My Alerts
  • Log in
  • Log out
Site Logo
  • Home
  • Latest Articles
  • Current Issue
  • Past Issues
  • Neurology Video Journal Club
  • Residents & Fellows

Share

December 01, 1998; 51 (6) Editorials

Even the dead are not terminally ill anymore

Ronald Cranford
First published December 1, 1998, DOI: https://doi.org/10.1212/WNL.51.6.1530
Ronald Cranford
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Full PDF
Citation
Even the dead are not terminally ill anymore
Ronald Cranford
Neurology Dec 1998, 51 (6) 1530-1531; DOI: 10.1212/WNL.51.6.1530

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Permissions

Make Comment

See Comments

Downloads
62

Share

  • Article
  • Info & Disclosures
Loading

The brain death debate is now 30 years old. Ever since the Harvard Ad Hoc criteria for brain death were published in August 1968, and the proposal was first made that the clinical diagnosis of brain death constituted the legal death of a human being (brain death as death), the brain death controversy has continued.1 However, except for a few unresolved issues, there has been a surprising degree of consensus on the major medical and legal aspects of this subject. One reason for this consensus has been the numerous sets of clinical criteria published by medical, pediatric, neurologic, and neurosurgical organizations in the United States and other countries. Even though these criteria varied somewhat in the clinical features essential to the diagnosis of brain death, the positions of these medical societies strongly supported the view that brain death was a highly reliable diagnosis in most cases.2 In the 1970s, when lawmakers were first involved in enacting statutory legislation equating brain death with death, they were informed by physicians that brain death was a medical syndrome that could be diagnosed with an extraordinarily high degree of certainty within hours or days after injury to the brain, and that brain death could be reliably distinguished at the bedside from other syndromes of severe brain damage, such as coma with some residual brainstem functions, the permanent vegetative state, and the locked-in syndrome.3 Kansas in 1970 and all states by the early 1990s had enacted statutory legislation or case law legalizing brain death as death.

Even though brain death has become accepted by the medical and legal communities over the last three decades, one of the major ongoing sources of controversy, at least in the minds of some scholars, has been the underlying philosophical-legal rationale as to why brain death should be considered equivalent to cardiorespiratory death as the death of a human being.4 One strong argument has been the medical view that the loss of all functions of the brain will inevitably lead to the loss of somatic integrative unity of the human organism (the somatic disintegration hypothesis). In other words, when the brain stops functioning, the vital functions of heartbeat and circulation will inevitably fail in a short period of time, regardless of aggressive treatment to sustain these vital functions. This somatic disintegration rationale proposed by clinicians was accepted by lawmakers and judges as a cornerstone of the legal basis for brain death as death.

Alan Shewmon, MD, in this issue of Neurology, has accumulated convincing data that, among other things, undermine this somatic disintegration hypothesis.5 Through his personal observations and those of other professionals, collection of articles from various sources, and systematic database searches, Shewmon found 175 cases of brain dead patients with "survival" times (sustained functions of heartbeat and circulation) of at least 1 week. In 56 of these cases there was sufficient reliable information for in-depth analysis of some clinical characteristics; age, etiology, and the terminal event (either treatment withdrawal or spontaneous cardiac arrest). Of these 56 cases subjected to analysis, 17 survived over 2 months, 7 over 6 months, and 4 over 1 year. Dr. Shewmon explores the various medical factors that could possibly account for these remarkable examples of prolonged survival.

Assuming the study data are valid, the article has important implications for the neurologist. The article documents and verifies the suspicion that some neurologists have experienced in the diagnosis of brain death: to some extent, the relation between brain death and survival time is a self-fulfilling prophecy. The prediction that brain dead patients will inevitably have a cardiac arrest within hours or days is not necessarily accurate. With advances in technology, we can keep patients "alive" for indefinite periods, even the "dead." Not only can we keep "terminally" ill patients alive for over 6 months (one definition of terminal illness), even the "dead" (brain dead patients) are not terminally ill anymore-if medicine were to advocate the unwise and inhumane policy of maintaining maximal treatment in brain dead patients until the point of refractory cardiac arrest.

It is impossible to know with certainty the extent of prolonged survival in brain death because a systematic clinical study in which the cardiac and circulatory functions are sustained for prolonged periods (weeks, months, or years) in a large number of patients is morally indefensible, extraordinarily expensive in terms of money and resources of manpower and intensive care unit beds, and legally prohibitive. Shewmon's article and the extensive case documentation, along with thoughtful concerns raised by scholars in recent years, create serious questions about the validity of the somatic disintegration basis for brain death as death and justify continued exploration of the issue.6,7 From a practical standpoint, we can not turn back the clock on the sensible medical and legal policies developed over the last 30 years. Brain death, both as a medical syndrome and a legal reality, is both well-accepted and valid. In the final analysis, Shewmon's article will not undermine the medical and legal doctrine of brain death as the death of a human being. However, understanding the existing arguments of the legal basis for death, whether valid or not, may have implications for other moral and legal controversies where consensus does not yet exist: the higher brain formulation of death, the legal and donor status of infants with anencephaly, and the non-heart-beating donor programs in major organ transplant centers.8-10

References

  1. 1.↵
    Report of the Ad Hoc Committee of the Harvard Medical School to Examine the Definition of Brain Death. A definition of irreversible coma. JAMA 1968;205:337-340.
    OpenUrl
  2. 2.↵
    Report of the Medical Consultants on the Diagnosis of Death. Guidelines for the determination of death. JAMA 1981;246:2184-2186.
    OpenUrl
  3. 3.↵
    President's Commission for the Study of Ethical Problems in Medicine and Biomedical and Behavioral Research. Defining death, Washington, DC: Government Printing Office, 1981.
  4. 4.↵
    Veatch RM. The impending collapse of the whole-brain definition of death. Hastings Cent Rep 1993;23(4):18-24.
  5. 5.↵
    Shewmon DA. Chronic "brain death": Meta-analysis and conceptual consequences. Neurology 1998;51:1538-1545.
    OpenUrlFREE Full Text
  6. 6.↵
    Truog RD. Is it time to abandon brain death? Hastings Cent Rep 1997;27(1):29-37.
  7. 7.
    Bernat JL. A defense of the whole-brain concept of death. Hastings Cent Rep 1998;28(2):14-23.
  8. 8.↵
    Medical Task Force on Anencephaly. The infant with anencephaly. N Engl J Med 1990;322:669-674.
    OpenUrl
  9. 9.
    Youngner S, Arnold R. Ethical, psychosocial, and public policy implications of procuring organs from non-heart-beating cadaver donors. JAMA 1993;269:2769-2774.
    OpenUrl
  10. 10.
    Plows CW. Reconsideration of AMA opinion on anencephalic neonates as organ donors. JAMA 1996;275:443-444.
    OpenUrlCrossRef
View Abstract

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top
  • Article
    • References
  • Info & Disclosures
Advertisement

Hemiplegic Migraine Associated With PRRT2 Variations A Clinical and Genetic Study

Dr. Robert Shapiro and Dr. Amynah Pradhan

► Watch

Related Articles

  • No related articles found.

Alert Me

  • Alert me when eletters are published
Neurology: 100 (4)

Articles

  • Ahead of Print
  • Current Issue
  • Past Issues
  • Popular Articles
  • Translations

About

  • About the Journals
  • Ethics Policies
  • Editors & Editorial Board
  • Contact Us
  • Advertise

Submit

  • Author Center
  • Submit a Manuscript
  • Information for Reviewers
  • AAN Guidelines
  • Permissions

Subscribers

  • Subscribe
  • Activate a Subscription
  • Sign up for eAlerts
  • RSS Feed
Site Logo
  • Visit neurology Template on Facebook
  • Follow neurology Template on Twitter
  • Visit Neurology on YouTube
  • Neurology
  • Neurology: Clinical Practice
  • Neurology: Education
  • Neurology: Genetics
  • Neurology: Neuroimmunology & Neuroinflammation
  • AAN.com
  • AANnews
  • Continuum
  • Brain & Life
  • Neurology Today

Wolters Kluwer Logo

Neurology | Print ISSN:0028-3878
Online ISSN:1526-632X

© 2023 American Academy of Neurology

  • Privacy Policy
  • Feedback
  • Advertise